Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
28,971
Total Claims
$4.9M
Drug Cost
719
Beneficiaries
$6,884
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-98%
Opioid rate vs peers
0.1% vs 2.2% avg
+388%
Cost per patient vs peers
$6,884 vs $1,411 avg
+90%
Brand preference vs peers
20.2% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
16
Opioid Claims
$843
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 5,802 claims · $4.1M
Generic: 22,942 claims · $849K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 1,059 | $432K |
| Denosumab | 189 | $326K |
| Dapagliflozin Propanediol | 455 | $295K |
| Diclofenac Epolamine | 156 | $289K |
| Semaglutide | 240 | $269K |
| Tenofovir Alafenamide | 149 | $221K |
| Lipase/Protease/Amylase | 180 | $210K |
| Cyclosporine | 221 | $147K |
| Finerenone | 176 | $147K |
| Semaglutide | 125 | $139K |
| Apixaban | 192 | $127K |
| Diclofenac Epolamine | 85 | $124K |
| Empagliflozin | 165 | $120K |
| Linaclotide | 182 | $116K |
| Diclofenac Sodium | 251 | $105K |
Prescribing Profile
Patient Profile
79
Avg Age
62%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data